NEUP earnings date and last-quarter result: next report 2026-09-02, last quarter beat, P/E -0.30. Updated 2026-07-23.
Neuphoria Therapeutics (NEUP) Research Hub
Neuphoria Therapeutics (NEUP) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 3.38 USD (-1.74%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.30, market cap 0.02B. This hub links to the full technical, earnings and options research available for NEUP.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.38 USD (-1.74%) |
| 52-week range | 3.23 USD – 4.64 USD |
| Trend regime | Range |
| 14-day RSI | 45.2 (Neutral) |
| Trailing P/E | -0.30 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-02 |
Available research for NEUP
Covered Call on NEUP: how it works, illustrative setup around the real 3.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NEUP: how it works, illustrative setup around the real 3.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NEUP: how it works, illustrative setup around the real 3.38 USD price, max profit/loss, breakeven and when to use it. Educational.
NEUP technical analysis: range, last 3.38 USD, RSI 45.2, 52w range 3.23 USD–4.64 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is NEUP in?
Neuphoria Therapeutics (NEUP) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is NEUP in an uptrend or downtrend?
As of 2026-10-26, NEUP is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NEUP's trailing P/E ratio?
NEUP's trailing P/E is -0.30, with a market cap of 0.02B. See the earnings research page for full valuation detail.
When does NEUP next report earnings?
NEUP is next scheduled to report earnings on 2026-09-02.